FIELD: organic chemistry, steroids, chemical technology, pharmacy. SUBSTANCE: invention describes some new steroid derivatives of the formula (I) wherein R3,R7,R12 represent independently OH, =O, C1-10-hydroxyalkyl, optionally substituted C1-10-aminoalkyl, possibly protected C1-10-hydroxyalkyloxy-group wherein OH-group is protected possibly, C2-10-acyloxy-group, possibly substituted C1-10-aminoalkyloxy-group, possibly substituted C1-10-aminoalkylcarboxy-group wherein amino-group is possibly protected or quaternized, H2N- HC(Q5)-C(O)-O- wherein Q5-side chain of any amino acid and amino-group is possibly protected, possibly substituted C1-10-guanidinoalkyloxy-group, C2-10-alkenyloxy-group, C1-10-cyanoalkyloxy-group, C1-10- azidoalkyloxy-group; R17 is possibly substituted C1-10-hydroxyalkyl wherein OH is optionally protected or optionally substituted C1-10-alkyloxy-C1-10-alkyl, optionally substituted C1-10-aminoalkyl, C2-10-acyl or its ketal derivatives, or binding group bound to the second steroid at position 17 wherein binding group represents C1-10- alkyleneoxy-C1-10-alkylene, or their pharmaceutically acceptable salts. Proposed compounds are antibacterial agents providing sensitivity of microorganisms (sensibilization) to effect of other antibiotics, among them erythromycin and novobiocin. EFFECT: improved preparing method, enhanced treatment method, valuable medicinal properties of compounds. 37 cl, 7 sch, 8 tbl, 8 ex
Title |
Year |
Author |
Number |
METHODS AND PRODUCTS FOR HEALING TISSUE WOUNDS |
2012 |
- Genberg Karl
- Savazh Pol B.
|
RU2652308C2 |
METHODS FOR TREATING INFLAMMATION, AUTOIMMUNE DISORDERS AND PAIN |
2014 |
- Sevadzh Pol B.
- Genberg Karl
|
RU2669800C2 |
MODIFIED 2- AND 3-NUCLEOSIDES AND USE THEREOF TO PRODUCE MEDICINAL AGENT, HAVING HEPATITIS C INHIBITING ACTIVITY |
2003 |
- Sommadossi Zhan-P'Er
- La Kolla Paolo
- Storer Richard
- Gosselin Zhil'
|
RU2437892C2 |
STABLE IN STORAGE ANTIMICROBIAL COMPOSITIONS INCLUDING CERAGENIN COMPOUNDS AND METHODS FOR APPLICATION THEREOF |
2011 |
|
RU2576459C2 |
PROMEDICINES OF MODIFIED 2'- AND 3'-NUCLEOSIDES FOR TREATMENT OF FLAVIVIRIDAE INFECTIONS |
2003 |
- Sommadossi Zhan-P'Er
- La Kolla Paolo
- Storer Richard
- Gosselin Zhil'
|
RU2366661C2 |
MODIFIED 2'- AND 3'-NUCLEOSIDES AND USE THEREOF FOR PREPARING DRUG FOR TREATING FLAVIVIRIDAE INFECTIONS |
2011 |
- Sommadossi Zhan-P'Er
- La Kolla Paolo
- Storer Richard
- Gosselin Zhil'
|
RU2483075C2 |
OXAZOLIDINONE DERIVATIVES, METHOD FOR PREPARING THEREOF (VERSIONS) AND BASED PHARMACEUTICAL COMPOSITION |
2006 |
- Gul'Etta Antonio
- Kano Montserrat
- Palomer Al'Bert
|
RU2417223C2 |
PHARMACOLOGICALLY ACTIVE COMPOUNDS AS INHIBITORS OF THE TAM FAMILY RECEPTOR TYROSINE KINASE |
2016 |
- Nam, Kijyan
- Kim, Dzhesyn
- An, Sokhen
- Chon, Edzhin
- Li, Dukhen
- Park, Donsik
- Yan, Enin
- Li, Seen
- Kim, Chondzhun
- An, Chije
- Kim, Khana
- Chzhun, Chon-Von
- Shults-Fademrekht, Karsten
|
RU2750727C2 |
COMBINATED INHIBITORS OF FBP-ASE AND ANTIDIABETIC AGENTS FOR DIABETES TREATMENT |
2001 |
- Van Pul'E Paul' D.
- Ehrion Mark D.
- Fudzivara Tosikhiko
|
RU2328308C2 |
COMBINATION OF INHIBITORS OF FBP-ASE AND SENSITIZING AGENTS OF INSULIN FOR DIABETES MELLITUS TREATMENT |
1999 |
- Ehrion Mark D.
- Van Pul'E Paul'
|
RU2227749C2 |